| pubmed-article:16675345 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16675345 | lifeskim:mentions | umls-concept:C0002092 | lld:lifeskim |
| pubmed-article:16675345 | lifeskim:mentions | umls-concept:C0026231 | lld:lifeskim |
| pubmed-article:16675345 | lifeskim:mentions | umls-concept:C0754728 | lld:lifeskim |
| pubmed-article:16675345 | lifeskim:mentions | umls-concept:C1704632 | lld:lifeskim |
| pubmed-article:16675345 | lifeskim:mentions | umls-concept:C0871261 | lld:lifeskim |
| pubmed-article:16675345 | lifeskim:mentions | umls-concept:C0023688 | lld:lifeskim |
| pubmed-article:16675345 | lifeskim:mentions | umls-concept:C2911692 | lld:lifeskim |
| pubmed-article:16675345 | lifeskim:mentions | umls-concept:C1706817 | lld:lifeskim |
| pubmed-article:16675345 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:16675345 | pubmed:dateCreated | 2006-5-5 | lld:pubmed |
| pubmed-article:16675345 | pubmed:abstractText | There is intense interest in the interaction between microbial compounds and allergy. Although Toll-like receptor (TLR)-2 ligands derived from Gram-positive bacteria alter allergic sensitization in animal models, it is not clear what effect TLR2 ligands have on allergen-specific T-cell memory in human beings. | lld:pubmed |
| pubmed-article:16675345 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16675345 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16675345 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:16675345 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16675345 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16675345 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16675345 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16675345 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16675345 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16675345 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16675345 | pubmed:month | May | lld:pubmed |
| pubmed-article:16675345 | pubmed:issn | 0091-6749 | lld:pubmed |
| pubmed-article:16675345 | pubmed:author | pubmed-author:UphamJohn WJW | lld:pubmed |
| pubmed-article:16675345 | pubmed:author | pubmed-author:RichmondPeter... | lld:pubmed |
| pubmed-article:16675345 | pubmed:author | pubmed-author:TaylorRebecca... | lld:pubmed |
| pubmed-article:16675345 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16675345 | pubmed:volume | 117 | lld:pubmed |
| pubmed-article:16675345 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16675345 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16675345 | pubmed:pagination | 1148-54 | lld:pubmed |
| pubmed-article:16675345 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:16675345 | pubmed:meshHeading | pubmed-meshheading:16675345... | lld:pubmed |
| pubmed-article:16675345 | pubmed:meshHeading | pubmed-meshheading:16675345... | lld:pubmed |
| pubmed-article:16675345 | pubmed:meshHeading | pubmed-meshheading:16675345... | lld:pubmed |
| pubmed-article:16675345 | pubmed:meshHeading | pubmed-meshheading:16675345... | lld:pubmed |
| pubmed-article:16675345 | pubmed:meshHeading | pubmed-meshheading:16675345... | lld:pubmed |
| pubmed-article:16675345 | pubmed:meshHeading | pubmed-meshheading:16675345... | lld:pubmed |
| pubmed-article:16675345 | pubmed:meshHeading | pubmed-meshheading:16675345... | lld:pubmed |
| pubmed-article:16675345 | pubmed:meshHeading | pubmed-meshheading:16675345... | lld:pubmed |
| pubmed-article:16675345 | pubmed:meshHeading | pubmed-meshheading:16675345... | lld:pubmed |
| pubmed-article:16675345 | pubmed:meshHeading | pubmed-meshheading:16675345... | lld:pubmed |
| pubmed-article:16675345 | pubmed:meshHeading | pubmed-meshheading:16675345... | lld:pubmed |
| pubmed-article:16675345 | pubmed:meshHeading | pubmed-meshheading:16675345... | lld:pubmed |
| pubmed-article:16675345 | pubmed:meshHeading | pubmed-meshheading:16675345... | lld:pubmed |
| pubmed-article:16675345 | pubmed:meshHeading | pubmed-meshheading:16675345... | lld:pubmed |
| pubmed-article:16675345 | pubmed:meshHeading | pubmed-meshheading:16675345... | lld:pubmed |
| pubmed-article:16675345 | pubmed:meshHeading | pubmed-meshheading:16675345... | lld:pubmed |
| pubmed-article:16675345 | pubmed:meshHeading | pubmed-meshheading:16675345... | lld:pubmed |
| pubmed-article:16675345 | pubmed:year | 2006 | lld:pubmed |
| pubmed-article:16675345 | pubmed:articleTitle | Toll-like receptor 2 ligands inhibit TH2 responses to mite allergen. | lld:pubmed |
| pubmed-article:16675345 | pubmed:affiliation | Telethon Institute for Child Health Research, Centre for Child Health Research, University of Western Australia, West Perth. | lld:pubmed |
| pubmed-article:16675345 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:16675345 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16675345 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16675345 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16675345 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16675345 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:16675345 | lld:pubmed |
